SUSQUEHANNA INTERNATIONAL GROUP, LLP - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114,255
-26.4%
88,570
-1.9%
0.00%
Q2 2023$155,216
-72.6%
90,242
-76.0%
0.00%
Q1 2023$567,436
+2593.2%
375,786
+2753.8%
0.00%
Q4 2022$21,069
+10.9%
13,168
-0.6%
0.00%
Q3 2022$19,000
-71.6%
13,250
-63.9%
0.00%
Q2 2022$67,000
-69.3%
36,725
-55.1%
0.00%
Q1 2022$218,000
-84.2%
81,801
-74.4%
0.00%
Q4 2021$1,384,000
+77.2%
319,406
+108.4%
0.00%
Q3 2021$781,000
-20.7%
153,286
-1.5%
0.00%
Q2 2021$985,000
-23.3%
155,566
-6.5%
0.00%
Q1 2021$1,285,000
+253.0%
166,358
+198.6%
0.00%
Q4 2020$364,000
+59.6%
55,718
+61.9%
0.00%
Q3 2020$228,000
+3.2%
34,424
+29.6%
0.00%
Q2 2020$221,000
+45.4%
26,571
+33.8%
0.00%
Q1 2020$152,000
+16.9%
19,852
+27.1%
0.00%
Q4 2019$130,000
-55.6%
15,618
-60.8%
0.00%
Q3 2019$293,000
-77.0%
39,815
-64.9%
0.00%
Q2 2019$1,272,000
+657.1%
113,451
+922.1%
0.00%
Q4 2018$168,000
-85.7%
11,100
-82.5%
0.00%
Q3 2018$1,177,000
+27.7%
63,600
+57.8%
0.00%
Q2 2018$922,000
+152.6%
40,300
+21.4%
0.00%
Q4 2016$365,000
-24.7%
33,186
+42.9%
0.00%
Q4 2015$485,00023,2220.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders